Search Within

Ellen Marlese Basu

Formats
  1. Meeting Abstract (57)
  2. Journal Article (45)
  3. Correspondence (1)
Groups
  1. Neuroblastoma Service (103)
  2. Pediatrics, Department of (103)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (64)
  4. GSK Faculty (64)
  5. Tow Center for Developmental Oncology (TCDO) (63)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (62)

More Groups

People
  1. Shakeel Modak (78)
  2. Brian Kushner (70)
  3. Stephen Roberts (64)
  4. Nai-Kong Cheung (61)
  5. Kim Kramer (39)
  6. Suzanne Wolden (20)

More People

Years
  1. 2025 (5)
  2. 2024 (9)
  3. 2023 (10)
  4. 2022 (6)
  5. 2021 (7)
  6. 2020 (13)

More Years

Publications
  1. Pediatric Blood and Cancer (37)
  2. Journal of Clinical Oncology (17)
  3. Neuro-Oncology (8)
  4. International Journal of Cancer (5)
  5. International Journal of Radiation Oncology, Biology, Physics (5)
  6. Cancer (4)

More Publications

Publishers
  1. Wiley Periodicals, Inc (37)
  2. American Society of Clinical Oncology (18)
  3. Oxford University Press (9)
  4. Elsevier Inc. (6)
  5. John Wiley & Sons (5)
  6. Wiley Blackwell (4)

More Publishers

Results (103)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • N9: Pilot study of novel shortened induction for high-risk neuroblastoma
    Meeting Abstract

    Kushner, B. H.; Mauguen, A.; Basu, E. M.; Cardenas, F. I.; Gerstle, J. T.; Kramer, K.; Modak, S.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with (131)I-omburtamab for leptomeningeal disease
    Journal Article

    Prasad, K.; Serencsits, B. E.; Chu, B. P.; Dauer, L. T.; Donzelli, M.; Basu, E.; Kramer, K.; Pandit-Taskar, N.
    EJNMMI Research (2024)

    Fulltext@MSK | Save
  • Ovarian function in female survivors of high-risk neuroblastoma
    Journal Article

    Jimenez-Kurlander, L.; DeRosa, A.; Kostrzewa, C. E.; Moskowitz, C. S.; Bogardus, K.; Antal, Z.; Wolden, S.; La Quaglia, M. P.; Basu, E. M.; Cardenas, F. I.; more...
    Pediatric Blood and Cancer (2024)

    Fulltext@MSK | Save
  • Long prime-boost interval and heightened anti-GD2 antibody response to carbohydrate cancer vaccine
    Journal Article

    Cheung, I. Y.; Mauguen, A.; Modak, S.; Basu, E. M.; Feng, Y.; Kushner, B. H.; Cheung, N. K.
    Vaccines (2024)

    Fulltext@MSK | Save
  • 18F-MFBG PET imaging in patients with neuroblastoma: Lesion targeting and comparison with MIBG
    Meeting Abstract

    Pandit-Taskar, N.; Mauguen, A.; Basu, E.; Price, A.; Behr, G.; Min, R.; Lyashchenko, S.; Schwartz, J.; Modak, S.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Stage 4N neuroblastoma before and during the era of anti-G(D2) immunotherapy
    Journal Article

    Kushner, B. H.; LaQuaglia, M. P.; Cardenas, F. I.; Basu, E. M.; Gerstle, J. T.; Kramer, K.; Roberts, S. S.; Wolden, S. L.; Cheung, N. K. V.; Modak, S.
    International Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Safety and efficacy of naxitamab plus modified dosing of GM-CSF for patients with high-risk neuroblastoma (HR-NB) in first complete remission (CR) or with primary refractory disease
    Meeting Abstract

    Kushner, B. H.; Modak, S.; Basu, E. M.; Iglesias Cardenas, F.; Kramer, K.; Roberts, S. S.; Cheung, N. K. V.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • (18)F-MFBG PET imaging in patients with neuroblastoma: Lesion targeting and comparison with MIBG
    Meeting Abstract

    Modak, S.; Mauguen, A.; Basu, E. M.; Price, A.; Behr, G.; Min, R.; Lyashchenko, S. K.; Schwartz, J.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Stage 4N neuroblastoma before and during the era of anti-GD2 immunotherapy
    Meeting Abstract

    Kushner, B. H.; Modak, S.; LaQuaglia, M. P.; Basu, E. M.; Gerstle, J. T.; Iglesias Cardenas, F.; Kramer, K.; Roberts, S. S.; Wolden, S. L.; Cheung, N. K. V.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma
    Journal Article

    Tringale, K. R.; Wolden, S. L.; Karajannis, M.; Haque, S.; Pasquini, L.; Yildirim, O.; Rosenblum, M.; Benhamida, J. K.; Cheung, N. K.; Souweidane, M.; more...
    Journal of Neuro-Oncology (2023)

    Fulltext@MSK | Save